Medical Devices
MD 2843 | 2014
CLINICAL CHEMISTRY ANALYZER MARKET by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research)
GLOBAL FORECAST TO 2019 Report Description
Table of Contents List of Tables Sample Tables Related Reports
MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright Š 2014 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
1 Š MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
1
INTRODUCTION
1.1
OBJECTIVES OF THE STUDY
MD 2843
To define, describe, and forecast the global clinical chemistry analyzers market on the basis of products, research areas, end users, and geographies
To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the revenue of market segments with respect to five geographical segments, namely, the Americas, Europe, BRIC, Japan, and the Rest of the World (RoW)
To strategically profile the key players and comprehensively analyze their market shares and core competencies2
To track and analyze competitive developments such as joint ventures, mergers and acquisitions, new product developments, and research and development in the clinical chemistry analyzers market
___________ 1. Micromarkets are defined as the further segments and subsegments of the global clinical chemistry analyzers market included in the report. 2. Core competencies of the companies are captured in terms of the key developments, SWOT analyses, and key strategies adopte d by them to sustain their positions in the market.
2 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
1.2
MD 2843
MARKET SCOPE
Clinical chemistry analyzers are various types of instruments and reagents, among others that are used in the analysis of body fluids, namely blood and urine.
This market study covers various clinical chemistry products (instruments, reagents, and others). The others section includes different types of accessories, services, and other instruments used in the clinical chemistry market
The study does not include point-of-care (POC) testing and patient self-testing instruments such as glucose-monitoring devices
The application segments of the clinical chemistry analyzers market included in this report are basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profile/kidney function panels, thyroid function panels, and specialty chemicals
Particulars
Scope The Americas (Canada, Mexico, Chile, the U.S., and the Rest of the Americas) Europe (France, Germany, Italy, Spain, the U.K., and the Rest of Europe)
Geography
BRIC (Brazil, China, India, and Russia) Japan Rest of the World
Historical Years
2012–2013
Base Year
2013
Projected Year
2014
Forecast Period
2014–2019
Revenue Currency
USD ($)
3 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
1.2.1
MD 2843
MARKETS COVERED
This research report categorizes the clinical chemistry analyzers market into the following segments:
FIGURE 1
GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET CLINICAL CHEMISTRY ANALYZERS MARKET
Products
Tests
Analyzers Reagents Other Products
End Users
Basic Metabolic Panel
Academic Research Institutes
Electrolyte Panel
Diagnostic Laboratories
Lectin Arrays Lipid Profile
Hospitals Other End Users
Geographies Americas BRIC Europe
Japan Rest of the World
Renal Profile
Thyroid Profile Specialty Chemicals
Clinical Chemistry Analyzers Market, by Product
Analyzers
Clinical Chemistry Analyzers, by Capacity
Small (400–800 Test/H)
Medium (800–1,200 Tests/H)
Large (1,200–2,000 Tests/H)
Very Large (2,000 Tests/H)
Reagents
Other Products
Clinical Chemistry Analyzers Market, by Test
Basic Metabolic Panels
Electrolyte Panels
Liver Panels
Lipid Profiles
Renal Profiles
Thyroid Function Panels
Specialty Chemicals 4
© MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
Clinical Chemistry Analyzers Market, by End User
Academic Research Institutes
Diagnostic Laboratories
Hospitals
Other End Users
Clinical Chemistry Analyzers Market, by Geography
The Americas
Canada
Chile
Mexico
U.S.
Rest of Americas (RoA)
BRIC
Brazil
China
India
Russia
Europe
France
Germany
Italy
Spain
U.K.
Rest of Europe (RoE)
Japan
Rest of the World (RoW)
1.3
STAKEHOLDERS
Clinical chemistry analyzers, reagents and accessories manufacturers and vendors, data management solutions users and providers
Associations related to clinical chemistry analyzers
Research institutes and CROs
Market research and consulting firms
5 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
TABLE OF CONTENTS 1
INTRODUCTION ........................................................................................................ 18 1.1
OBJECTIVES OF THE STUDY ...........................................................................................................18
1.2
MARKET SCOPE............................................................................................................................19 1.2.1
1.3
2
MARKETS COVERED ....................................................................................................... 20
STAKEHOLDERS ...........................................................................................................................21
RESEARCH METHODOLOGY ...................................................................................... 22 2.1
MARKET SIZE ESTIMATION ............................................................................................................23
2.2
MARKET CRACKDOWN AND DATA TRIANGULATION ........................................................................25
2.3
MARKET SHARE ESTIMATION ........................................................................................................26 2.3.1
KEY DATA FROM SECONDARY SOURCES ......................................................................... 26
2.3.2
KEY DATA FROM PRIMARY SOURCES .............................................................................. 27 2.3.2.1
2.3.3
Key Industry Insights.......................................................................................... 27
ASSUMPTIONS............................................................................................................... 28
3
EXECUTIVE SUMMARY .............................................................................................. 29
4
PREMIUM INSIGHTS ................................................................................................ 32
5
4.1
CLINICAL CHEMISTRY ANALYZERS MARKET TO GROW AT A MODEST RATE......................................32
4.2
LIFE CYCLE ANALYSIS, BY REGION ................................................................................................33
MARKET OVERVIEW.................................................................................................. 35 5.1
INTRODUCTION ............................................................................................................................36
5.2
MARKET SEGMENTATION ..............................................................................................................36
5.3
5.2.1
CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT ............................................... 36
5.2.2
CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST ....................................................... 36
5.2.3
CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER .............................................. 37
MARKET DYNAMICS......................................................................................................................37 5.3.1
5.3.2
DRIVERS ........................................................................................................................ 38 5.3.1.1
Increasing healthcare expenditure ..................................................................... 38
5.3.1.2
Rapidly aging population is an important indirect driver for this market .............................................................................................................. 39
5.3.1.3
Increasing prevalence of lifestyle diseases ......................................................... 40
5.3.1.4
Increase in laboratory automation...................................................................... 40
5.3.1.5
Rise in the number of reagent rental agreements ................................................ 40
5.3.1.6
Increase in access to medical insurance in the U.S. market................................. 40
RESTRAINTS................................................................................................................... 41 5.3.2.1
Requirement of high capital investments............................................................ 41
5.3.2.2
Stringent regulatory policies for medical devices ................................................ 41 6
© MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
5.3.2.3 5.3.3
6
5.3.4.1
Quick turnaround times ..................................................................................... 42
5.3.4.2
High throughput ................................................................................................ 42
5.3.4.3
Demand for modular automation ....................................................................... 42
INTRODUCTION ............................................................................................................................43
6.2
PORTER’S FIVE FORCES ANALYSIS ................................................................................................43
6.4
6.2.1
THREAT FROM NEW ENTRANTS ....................................................................................... 44
6.2.2
THREAT FROM SUBSTITUTES .......................................................................................... 44
6.2.3
BARGAINING POWER OF BUYERS ................................................................................... 44
6.2.4
BARGAINING POWER OF SUPPLIERS .............................................................................. 44
6.2.5
COMPETITIVE RIVALRY AMONG EXISTING PLAYERS ......................................................... 44
STRATEGIC BENCHMARKING ........................................................................................................45 NEW PRODUCT LAUNCHES ............................................................................................. 45
SUPPLY CHAIN ANALYSIS .............................................................................................................46 6.4.1
9
TRENDS ......................................................................................................................... 42
6.1
6.3.1
8
Growing opportunities in emerging economies ................................................... 41
INDUSTRY INSIGHTS ................................................................................................ 43
6.3
7
High degree of consolidation to act as an entry barrier for new entrants ............................................................................................................ 41
OPPORTUNITIES ............................................................................................................. 41 5.3.3.1
5.3.4
MD 2843
KEY INFLUENCERS ......................................................................................................... 47
CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT......................................... 48 7.1
INTRODUCTION ............................................................................................................................49
7.2
ANALYZERS ..................................................................................................................................50
7.3
REAGENTS ...................................................................................................................................53
7.4
OTHER PRODUCTS ........................................................................................................................55
CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST ................................................ 56 8.1
INTRODUCTION ............................................................................................................................57
8.2
BASIC METABOLIC PANELS ..........................................................................................................58
8.3
ELECTROLYTE PANELS ..................................................................................................................60
8.4
LIVER PANELS ..............................................................................................................................61
8.5
LIPID PROFILES ............................................................................................................................62
8.6
RENAL PROFILES ..........................................................................................................................64
8.7
THYROID FUNCTION PANELS .........................................................................................................66
8.8
SPECIALTY CHEMICAL TESTS ........................................................................................................67
CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USERS...................................... 68 9.1
INTRODUCTION ............................................................................................................................69
9.2
ACADEMIC RESEARCH CENTERS ..................................................................................................70
9.3
DIAGNOSTIC LABORATORIES ........................................................................................................71 7
© MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
9.4
HOSPITALS...................................................................................................................................72
9.5
OTHER END USERS .......................................................................................................................73
10 GEOGRAPHIC ANALYSIS ........................................................................................... 75 10.1
INTRODUCTION ............................................................................................................................76
10.2
THE AMERICAS .............................................................................................................................79
10.3
10.4
10.2.1
CANADA......................................................................................................................... 86
10.2.2
CHILE............................................................................................................................. 89
10.2.3
MEXICO ......................................................................................................................... 92
10.2.4
U.S. ............................................................................................................................... 95
10.2.5
REST OF THE AMERICAS (ROA)........................................................................................ 98
BRIC ..........................................................................................................................................101 10.3.1
BRAZIL .........................................................................................................................107
10.3.2
CHINA ..........................................................................................................................110
10.3.3
INDIA ...........................................................................................................................113
10.3.4
RUSSIA ........................................................................................................................116
EUROPE .....................................................................................................................................119 10.4.1
FRANCE .......................................................................................................................126
10.4.2
GERMANY ....................................................................................................................129
10.4.3
ITALY............................................................................................................................132
10.4.4
SPAIN ..........................................................................................................................135
10.4.5
U.K. .............................................................................................................................138
10.4.6
REST OF EUROPE (ROE) ................................................................................................141
10.5
JAPAN ........................................................................................................................................144
10.6
REST OF THE WORLD (ROW) ........................................................................................................149
11 COMPETITIVE LANDSCAPE ..................................................................................... 154 11.1
INTRODUCTION ..........................................................................................................................154
11.2
MARKET SHARE ANALYSIS: CLINICAL CHEMISTRY ANALYZERS MARKET .......................................155
11.3
COMPETITIVE SITUATION AND TRENDS........................................................................................157 11.3.1
NEW PRODUCT LAUNCHES ...........................................................................................157
11.3.2
ACQUISITIONS .............................................................................................................158
11.3.3
AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS ...............................................159
11.3.4
EXPANSIONS................................................................................................................160
11.3.5
OTHER DEVELOPMENTS ...............................................................................................161
12 COMPANY PROFILES .............................................................................................. 162 12.1
INTRODUCTION ..........................................................................................................................162
12.2
ABBOTT LABORATORIES .............................................................................................................163
12.3
DANAHER CORPORATION ...........................................................................................................166
12.4
F. HOFFMANN-LA ROCHE LTD. ....................................................................................................169
12.5
JOHNSON & JOHNSON................................................................................................................173 8
© MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
12.6
SIEMENS AG ..............................................................................................................................176
12.7
ELITECH GROUP .........................................................................................................................179
12.8
HORIBA, LTD. .............................................................................................................................180
12.9
MINDRAY MEDICAL INTERNATIONAL LIMITED ..............................................................................183
12.10
RANDOX LABORATORIES LTD. .....................................................................................................186
12.11
THERMO FISHER SCIENTIFIC INC. ...............................................................................................188
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
13 APPENDIX .............................................................................................................. 190 13.1
INSIGHTS OF INDUSTRY EXPERTS ...............................................................................................190
13.2
DISCUSSION GUIDE ...................................................................................................................190
13.3
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE .................................................................192
13.4
AVAILABLE CUSTOMIZATIONS .....................................................................................................194
13.5
RELATED REPORTS .....................................................................................................................194
9 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
LIST OF TABLES U
TABLE 1
MARKET DEVELOPMENTS BETWEEN 2011 AND 2014
45
TABLE 2
GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
50
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
52
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
53
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
58
BASIC METABOLIC PANEL TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
59
TABLE 7
ELECTROLYTE PANEL TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
60
TABLE 8
LIVER PANEL TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
62
TABLE 9
LIPID PROFILE TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
64
TABLE 10
RENAL PROFILE TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
65
TABLE 11
THYROID FUNCTION PANEL TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
66
TABLE 12
SPECIALTY CHEMICAL TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
67
TABLE 13
CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2012–2019 ($MILLION)
70
GLOBAL CLINICAL CHEMISTRY MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2012–2019 ($MILLION)
71
CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2012–2019 ($MILLION)
72
GLOBAL CLINICAL CHEMISTRY MARKET FOR HOSPITALS, BY REGION, 2012–2019 ($MILLION)
73
GLOBAL CLINICAL CHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2012–2019 ($MILLION)
74
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
78
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
81
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
82
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
83
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
84
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
85
CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
87
CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
88
CHILE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
90
TABLE 3 TABLE 4 TABLE 5 TABLE 6
TABLE 14 TABLE 15 TABLE 16 TABLE 17 TABLE 18 TABLE 19 TABLE 20 TABLE 21 TABLE 22 TABLE 23 TABLE 24 TABLE 25 TABLE 26
10 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
TABLE 27 TABLE 28 TABLE 29 TABLE 30 TABLE 31 TABLE 32 TABLE 33 TABLE 34 TABLE 35 TABLE 36 TABLE 37 TABLE 38 TABLE 39 TABLE 40 TABLE 41 TABLE 42 TABLE 43 TABLE 44 TABLE 45 TABLE 46 TABLE 47 TABLE 48 TABLE 49 TABLE 50 TABLE 51 TABLE 52
MD 2843
CHILE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
91
MEXICO: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
93
MEXICO: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
94
U.S.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
96
U.S.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
97
ROA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
99
ROA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
100
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
102
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
103
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
104
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
105
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
106
BRAZIL: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
108
BRAZIL: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
109
CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
111
CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
112
INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
114
INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
115
RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
117
RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
118
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
121
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
122
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
123
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
124
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
125
FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
127 11
© MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
TABLE 53
MD 2843
FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
128
GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
130
GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
131
ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
133
ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
134
SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
136
SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
137
U.K.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
139
U.K.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
140
ROE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
142
ROE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
143
JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
145
JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
146
JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
147
JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
148
ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
150
ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
151
ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)
152
ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
153
TABLE 72
NEW PRODUCT LAUNCHES, 2011–2014
157
TABLE 73
ACQUISITIONS, 2011–2014
158
TABLE 74
AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011–2014
159
TABLE 75
EXPANSIONS, 2011–2014
160
TABLE 76
OTHER DEVELOPMENTS, 2011–2014
161
TABLE 54 TABLE 55 TABLE 56 TABLE 57 TABLE 58 TABLE 59 TABLE 60 TABLE 61 TABLE 62 TABLE 63 TABLE 64 TABLE 65 TABLE 66 TABLE 67 TABLE 68 TABLE 69 TABLE 70 TABLE 71
12 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
LIST OF FIGURES FIGURE 1
GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET
20
FIGURE 2
RESEARCH METHODOLOGY
22
FIGURE 3
MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
24
FIGURE 4
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
24
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
25
FIGURE 6
DATA TRIANGULATION METHODOLOGY
26
FIGURE 7
REAGENTS IS THE LARGEST AND FASTEST-GROWING PRODUCT SEGMENT
29
FIGURE 8
BASIC METABOLIC PANEL IS THE LARGEST TEST SEGMENT IN 2014
30
FIGURE 9
HOSPITALS WILL DOMINATE THE CLINICAL CHEMISTRY ANALYZERS MARKET BY 2019
30
BRIC IS THE FASTEST-GROWING REGION IN THE CLINICAL CHEMISTRY ANALYZERS MARKET
31
INCREASING HEALTHCARE EXPENDITURE AND RISING DEMAND FROM BRIC ARE IMPORTANT GROWTH DRIVERS
32
REAGENTS TO ACCOUNT FOR THE MAXIMUM MARKET SHARE IN THE CLINICAL CHEMISTRY ANALYZERS MARKET
32
FIGURE 13
BRIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
33
FIGURE 14
BRIC MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
33
FIGURE 15
MARKET SEGMENTATION: BY PRODUCT
36
FIGURE 16
MARKET SEGMENTATION: BY TEST
37
FIGURE 17
MARKET SEGMENTATION: BY END USER
37
FIGURE 18
INCREASE IN HEALTHCARE EXPENDITURE WILL BE THE PRIMARY GROWTH DRIVER IN THIS MARKET
38
INCREASING HEALTHCARE EXPENDITURE IS THE MOST IMPORTANT DRIVER FOR THE CLINICAL CHEMISTRY ANALYZERS MARKET
39
POPULATION OF PEOPLE OVER 65 YEARS IS INCREASING AT CLOSE TO TWICE THE RATE OF THE GENERAL POPULATION
39
GROWTH IN HEALTHCARE EXPENDITURE IN BRIC AND ROW OUTPACING THAT IN AMERICAS AND EUROPE
42
FIGURE 22
PORTER’S FIVE FORCES ANALYSIS
43
FIGURE 23
MOST MARKET PLAYERS ADOPTED ORGANIC GROWTH STRATEGY OF NEW PRODUCT LAUNCHES BETWEEN 2011 AND 2014
46
FIGURE 24
SUPPLY CHAIN ANALYSIS
47
FIGURE 25
CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT
49
FIGURE 26
GLOBAL CLINICAL CHEMISTRY MARKET SHARE, BY PRODUCT, 2012–2019
49
FIGURE 27
CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENTATION, BY CAPACITY
51
FIGURE 28
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION)
52
CLINICAL CHEMISTRY REAGENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
54
CLINICAL CHEMISTRY REAGENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
54
FIGURE 10 FIGURE 11 FIGURE 12
FIGURE 19 FIGURE 20 FIGURE 21
FIGURE 29 FIGURE 30
13 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
FIGURE 31
MD 2843
CLINICAL CHEMISTRY OTHER PRODUCTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
55
CLINICAL CHEMISTRY OTHER PRODUCTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
55
FIGURE 33
CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST
57
FIGURE 34
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2014 (MARKET SIZE AND GROWTH RATES)
57
AMERICAS TO ACCOUNT FOR THE LARGEST SHARE IN THE BASIC METABOLIC PANEL SEGMENT
59
AMERICAS TO ACCOUNT FOR THE LARGEST SHARE OF THE ELECTROLYTE PANEL TEST SEGMENT
60
FIGURE 37
BRIC TO GROW AT THE HIGHEST CAGR IN THE LIVER PANEL TESTS MARKET
61
FIGURE 38
INCREASED OBESITY RATES TO AID THE GROWTH OF THE LIPID PROFILE TESTS SEGMENT
63
FIGURE 39
BRIC TO BE THE FASTEST-GROWING MARKET FOR LIPID PROFILE TESTS
63
FIGURE 40
BRIC IS EXPECTED TO BE THE FASTEST-GROWING MARKET FOR RENAL PROFILE TESTS
65
FIGURE 41
AMERICAS IS THE LARGEST MARKET FOR THYROID FUNCTION PANEL TESTS
66
FIGURE 42
AMERICAS ARE THE LARGEST MARKET FOR SPECIALTY CHEMICAL TESTS
67
FIGURE 43
CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER
69
FIGURE 44
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2014 (MARKET SIZE AND GROWTH RATES)
69
AMERICA HOLDS LARGEST SHARE OF CLINICAL CHEMISTRY ANALYZERS MARKET FOR ACADEMIC RESEARCH INSTITUTES
70
THE AMERICAS HOLDS LARGEST SHARE OF CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES
71
BRIC HOSPITALS SEGMENT EXPECTED TO SHOW FASTEST GROWTH IN CLINICAL CHEMISTRY ANALYZERS MARKET
72
BRIC REGIONAL SEGMENT SHOWS HIGHEST GROWTH IN CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS
73
FIGURE 49
CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION
76
FIGURE 50
GLOBAL ECONOMIC INDICATORS (2003–2012)
77
FIGURE 51
CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2014-2019
78
FIGURE 52
AMERICAS: ECONOMIC INDICATORS (2003–2012)
79
FIGURE 53
AMERICAS: MARKET SNAPSHOT
80
FIGURE 54
AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2014-2019
81
REAGENTS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE AMERICAS IN 2014
82
THE AMERICAS: MEDIUM-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR FROM 2014 TO 2019
83
THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST (MARKET SIZE AND GROWTH RATE), 2014–2019
84
HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS END-USERS MARKET IN THE AMERICAS
85
FIGURE 59
CANADA: ECONOMIC INDICATORS (2003–2012)
86
FIGURE 60
REAGENTS ARE THE LARGEST AND THE FASTEST-GROWING PRODUCT SEGMENT IN CANADA- 2014-2019
87
FIGURE 32
FIGURE 35 FIGURE 36
FIGURE 45 FIGURE 46 FIGURE 47 FIGURE 48
FIGURE 55 FIGURE 56 FIGURE 57 FIGURE 58
14 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
FIGURE 61
MD 2843
SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN CANADA- 2014-2019
88
FIGURE 62
CHILE: ECONOMIC INDICATORS (2003–2012)
89
FIGURE 63
REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS MARKET IN CHILE- 2014-2019
90
FIGURE 64
CHILE: SMALL-SIZED ANALYZERS TO GROW AT HIGHEST CAGR FROM 2014-2019
91
FIGURE 65
MEXICO: ECONOMIC INDICATORS (2003–2012)
92
FIGURE 66
REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN MEXICO
93
FIGURE 67
MEXICO: SMALL-SIZED ANALYZERS TO WITNESS THE HIGHEST GROWTH
94
FIGURE 68
U.S.: ECONOMIC INDICATORS (2003–2012)
95
FIGURE 69
REAGENTS ARE THE LARGEST PRODUCT SEGMENT IN THE U.S.
96
FIGURE 70
U.S.: MEDIUM-SIZED ANALYZERS TO WITNESS HIGHEST GROWTH
97
FIGURE 71
ROA: ECONOMIC INDICATORS (2003–2012)
98
FIGURE 72
REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN THE ROA
99
FIGURE 73
ROA: SMALL-SIZED ANALYZERS TO GROW AT HIGHEST CAGR
100
FIGURE 74
BRIC: ECONOMIC INDICATORS (2003–2012)
101
FIGURE 75
BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY (MARKET SIZE AND GROWTH RATE), 2014-2019
102
REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS MARKET IN BRIC IN 2014
103
FIGURE 77
BRIC: SMALL-SIZED ANALYZERS TO WITNESS HIGHEST CAGR
104
FIGURE 78
LIPID PROFILE IS THE FASTEST-GROWING TEST SEGMENT IN BRIC BETWEEN 2014 AND 2019
105
HOSPITALS ARE THE LARGEST AND THE FASTEST-GROWING END-USER SEGMENT IN BRIC
106
FIGURE 80
BRAZIL: ECONOMIC INDICATORS (2003–2012)
107
FIGURE 81
BRAZIL: THE REAGENTS SEGMENT TO WITNESS HIGHEST GROWTH
108
FIGURE 82
BRAZIL: SMALL-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR
109
FIGURE 83
CHINA: ECONOMIC INDICATORS (2003–2012)
110
FIGURE 84
REAGENTS ARE THE LARGEST PRODUCT SEGMENT IN CHINA
111
FIGURE 85
CHINA: SMALL-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR
112
FIGURE 86
INDIA: ECONOMIC INDICATORS (2003–2012)
113
FIGURE 87
REAGENTS ARE THE LARGEST AND THE FASTEST-GROWING PRODUCT SEGMENT IN INDIA
113
FIGURE 88
INDIA: SMALL-SIZED ANALYZERS TO WITNESS HIGHEST GROWTH
115
FIGURE 89
RUSSIA: ECONOMIC INDICATORS (2003–2012)
116
FIGURE 90
REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN RUSSIA
117
FIGURE 91
SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZER SEGMENT IN RUSSIA
118
FIGURE 92
EUROPE: ECONOMIC INDICATORS (2003–2012)
119
FIGURE 93
EUROPE: MARKET SNAPSHOT
120
FIGURE 94
EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2014-2019 (MARKET SIZE AND GROWTH RATES)
121
REAGENTS ARE THE LARGEST REVENUE CONTRIBUTORS TO CLINICAL CHEMISTRY ANALYZERS MARKET IN EUROPE IN 2014
122
MEDIUM-SIZED ANALYZERS TO HOLD LARGEST MARKET SHARE IN EUROPE
123
FIGURE 76
FIGURE 79
FIGURE 95 FIGURE 96
15 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
FIGURE 97
MD 2843
LIPID PROFILE TO BE FASTEST-GROWING TEST SEGMENT OF CLINICAL CHEMISTRY ANALYZERS MARKET IN EUROPE
124
FIGURE 98
HOSPITALS TO HOLD LARGEST MARKET SHARE IN EUROPE
125
FIGURE 99
FRANCE: ECONOMIC INDICATORS (2003–2012)
126
FIGURE 100
REAGENTS TO WITNESS HIGHEST GROWTH IN FRANCE BY 2019
127
FIGURE 101
MEDIUM-SIZED ANALYZERS MARKET TO WITNESS HIGHEST GROWTH
128
FIGURE 102
GERMANY: ECONOMIC INDICATORS (2003–2012)
129
FIGURE 103
REAGENTS TO WITNESS HIGHEST GROWTH RATE IN GERMANY BY 2019
130
FIGURE 104
MEDIUM-SIZED ANALYZERS SEGMENT TO WITNESS HIGHEST GROWTH
131
FIGURE 105
ITALY: ECONOMIC INDICATORS (2003–2012)
132
FIGURE 106
REAGENTS TO WITNESS HIGHEST GROWTH RATE IN ITALY BY 2019
133
FIGURE 107
SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN ITALY
134
FIGURE 108
SPAIN: ECONOMIC INDICATORS (2003–2012)
135
FIGURE 109
REAGENTS TO WITNESS HIGHEST GROWTH RATE IN SPAIN BY 2019
136
FIGURE 110
SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN SPAIN
137
FIGURE 111
U.K.: ECONOMIC INDICATORS (2003–2012)
138
FIGURE 112
REAGENTS TO WITNESS HIGHEST GROWTH RATE IN THE U.K. BY 2019
139
FIGURE 113
MEDIUM-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN THE U.K.
140
FIGURE 114
ROE: ECONOMIC INDICATORS (2003–2012)
141
FIGURE 115
REAGENTS TO WITNESS HIGHEST GROWTH RATE IN ROE BY 2019
142
FIGURE 116
SMALL-SIZED ANALYZERS TO BE FASTEST-GROWING SEGMENT IN ROE
143
FIGURE 117
JAPAN: ECONOMIC INDICATORS (2003–2012)
144
FIGURE 118
REAGENTS ARE ESTIMATED TO COMMAND LARGEST SHARE OF THE TOTAL CLINICAL CHEMISTRY ANALYZERS MARKET IN JAPAN IN 2014
145
FIGURE 119
MEDIUM-SIZED ANALYZERS TO COMMAND LARGEST MARKET SHARE IN JAPAN
146
FIGURE 120
LIPID PROFILES TO BE THE FASTEST-GROWING TEST SEGMENT IN CLINICAL CHEMISTRY ANALYZERS MARKET IN JAPAN
147
FIGURE 121
HOSPITALS TO COMMAND LARGEST SHARE OF END-USER MARKET IN JAPAN
148
FIGURE 122
ROW: ECONOMIC INDICATORS (2003–2012)
149
FIGURE 123
REAGENTS COMMAND LARGEST SHARE OF TOTAL CLINICAL CHEMISTRY ANALYZERS MARKET IN THE ROW
150
FIGURE 124
MEDIUM-SIZE ANALYZERS TO HOLD LARGEST SHARE IN EUROPE
151
FIGURE 125
LIPID PROFILES TO BE THE FASTEST-GROWING TEST SEGMENT IN ROW
152
FIGURE 126
HOSPITALS TO COMMAND LARGEST SHARE OF END-USER MARKET IN ROW
153
FIGURE 127
PRODUCT INNOVATIONS IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL CHEMISTRY ANALYZERS MARKET
154
GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
155
FIGURE 129
NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY
157
FIGURE 130
GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS
162
FIGURE 131
ABBOTT LABORATORIES: BUSINESS OVERVIEW
163
FIGURE 132
DANAHER CORPORATION: BUSINESS OVERVIEW
166
FIGURE 133
F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
169
FIGURE 128
16 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
FIGURE 134
JOHNSON & JOHNSON: BUSINESS OVERVIEW
173
FIGURE 135
SIEMENS AG: BUSINESS OVERVIEW
176
FIGURE 136
HORIBA, LTD.: BUSINESS OVERVIEW
180
FIGURE 137
MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
183
FIGURE 138
THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
188
17 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
SAMPLE TABLES TABLE 1
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012–2019 ($MILLION) Capacity
2012
2013
2014
CAGR% (2014–2019)
2019
Small
XX
XX
XX
XX
XX
Medium
XX
XX
XX
XX
XX
Large
XX
XX
XX
XX
XX
Very Large
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Investor Presentations, American Association of Clinical Chemistry, GLOBOCAN 2012, World Bank, World Health Organization, World Intellectual Property Organization, Expert Interviews, and MarketsandMarkets Analysis
The medium-sized analyzers segment is expected to account for largest share of XX% of the global clinical chemistry analyzers market in 2014. This product segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
TABLE 2
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) Region
2012
2013
2014
CAGR% (2014–2019)
2019
Americas
XX
XX
XX
XX
XX
BRIC
XX
XX
XX
XX
XX
Europe
XX
XX
XX
XX
XX
Japan
XX
XX
XX
XX
XX
RoW
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Investor Presentations, American Association of Clinical Chemistry, GLOBOCAN 2012, World Bank, World Health Organization, World Intellectual Property Organization, Expert Interviews, and MarketsandMarkets Analysis
In 2014, the Americas are expected to account for the largest share of XX% of the global clinical chemistry analyzers segment market in 2014. This geographical segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.
18 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
TABLE 3
MD 2843
CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION) Tests
2012
2013
2014
CAGR% (2014–2019)
2019
Basic Metabolic Panel
XX
XX
XX
XX
XX
Electrolyte Panel
XX
XX
XX
XX
XX
Liver Panel
XX
XX
XX
XX
XX
Lipid Profile
XX
XX
XX
XX
XX
Renal Profile
XX
XX
XX
XX
XX
Thyroid Function Panel
XX
XX
XX
XX
XX
Specialty Chemicals
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: Annual Reports, SEC Filings, Investor Presentations, American Association of Clinical Chemistry, GLOBOCAN 2012, World Bank, World Health Organization, World Intellectual Property Organization, Expert Interviews, and MarketsandMarkets Analysis
In 2014, the basic metabolic panel segment is expected to account for the largest share of XX% of the clinical chemistry analyzers market. This segment is poised to reach $XXmillion by 2019 from $XX million in 2014, at a CAGR of XX% during the forecast period.
19 © MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
RELATED REPORTS Report Title Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, NonSmall Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
Published Date
April 2014
http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
April 2014
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
20 Š MarketsandMarkets
Clinical Chemistry Analyzer Market – Global Forecast to 2019
MD 2843
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com
21 Š MarketsandMarkets